Low Grade Fallopian Tube Serous Adenocarcinoma

general

A slow-growing serous adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of low grade cytologic features and infrequent mitotic figures.

Centers

134

Active Trials

$1.3B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma	40	43
Refractory Low Grade Fallopian Tube Serous Adenocarcinoma	35	35

Top Centers for Low Grade Fallopian Tube Serous Adenocarcinoma(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	50.9
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	2	—	50.9
3	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
4	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
5	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
6	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
7	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
8	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
9	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
10	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
11	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
12	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
13	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
14	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
15	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
16	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	4	—	50.9
17	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
18	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	2	—	50.9
19	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
20	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
21	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	4	—	50.9
22	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
23	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
24	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
25	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	4	—	50.9
26	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
27	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	3	—	50.9
28	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
29	UMass Memorial Health Cancer CenterWorcester, MA Active Research Program	Active Research Program	1	—	50.9
30	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	3	—	50.9
31	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
32	Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
33	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	3	—	50.9
34	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
35	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
36	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	3	—	50.9
37	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	3	—	50.9
38	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	3	—	50.9
39	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	3	—	50.9
40	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	50.9
41	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	50.9
42	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	3	—	50.9
43	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	3	—	50.9
44	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	1	—	50.9
45	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	3	—	50.9
46	The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program	Active Research Program	1	—	50.9
47	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	3	—	50.9
48	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	50.9
49	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	50.9
50	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	3	—	50.9
51	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	3	—	50.9
52	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	3	—	50.9
53	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	1	—	50.9
54	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	1	—	50.9
55	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	3	—	50.9
56	Princess Margaret Cancer CentreToronto, ON Active Research Program	Active Research Program	1	—	50.9
57	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		2	$509M	—
58	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		1	$375M	—
59	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		2	$262M	—
60	Medical College of Wisconsin Cancer CenterMilwaukee, WI		2	$181M	—
61	Northwell Health Cancer InstituteNew York, NY		2	$18M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →